• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苔藓抑素1使人类宫颈癌细胞对顺二氯二氨铂(II)敏感化。

Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.

作者信息

Basu A, Lazo J S

机构信息

Department of Pharmacology, University of Pittsburgh School of Medicine, Pennsylvania 15261.

出版信息

Cancer Res. 1992 Jun 1;52(11):3119-24.

PMID:1591725
Abstract

Bryostatins are an important class of protein kinase C (PKC) activators. We have investigated the effect of bryostatin 1 on the antiproliferative activity of cis-diamminedichloroplatinum(II) (CP). A 24-h pretreatment of HeLa cells with 1 nM bryostatin 1 increased cellular sensitivity to CP by 4-fold. The effect of bryostatin 1 on the IC50 of CP (concentration of drug required to inhibit cell proliferation by 50%) was concentration-dependent and biphasic; the maximum effect of bryostatin 1 was seen with 1 nM, but higher concentrations of bryostatin 1 (greater than or equal to 10 nM) produced less CP sensitization. Although bryostatin 1 and phorbol esters caused an equivalent stimulation of HeLa cell PKC in cell-free systems, bryostatin 1 was less effective than phorbol esters in sensitizing cells to CP. Additionally, higher concentrations of bryostatin 1 (greater than or equal to 10 nM) antagonized CP sensitization by phorbol esters. Bryostatin 1 was even more potent than 12-O-tetradecanoylphorbol-13-acetate in inducing PKC down-regulation, and the maximum down-regulation was achieved with 10 nM bryostatin 1. Bryostatin 1 also increased cellular sensitivity to a CP analogue, cis-dichloro(ethylenediamine)platinum(II). A 24-h pretreatment with 1 nM bryostatin 1 increased cellular cis-[3H]DEP by 60%. The concentration- and time-dependent enhancement in CP sensitivity by bryostatin 1 was related to the increase in cis-[3H]DEP level. Thus, cellular accumulation of CP may be regulated by a PKC-dependent phosphorylation event.

摘要

苔藓抑素是一类重要的蛋白激酶C(PKC)激活剂。我们研究了苔藓抑素1对顺二氯二氨铂(II)(CP)抗增殖活性的影响。用1 nM苔藓抑素1对HeLa细胞进行24小时预处理,可使细胞对CP的敏感性提高4倍。苔藓抑素1对CP的IC50(抑制细胞增殖50%所需的药物浓度)的影响呈浓度依赖性且具有双相性;苔藓抑素1在1 nM时效果最佳,但更高浓度(大于或等于10 nM)的苔藓抑素1对CP的增敏作用较小。尽管在无细胞系统中苔藓抑素1和佛波酯对HeLa细胞PKC的刺激作用相当,但在使细胞对CP敏感方面,苔藓抑素1的效果不如佛波酯。此外,更高浓度(大于或等于10 nM)的苔藓抑素1会拮抗佛波酯对CP的增敏作用。在诱导PKC下调方面,苔藓抑素1比12 - O - 十四酰佛波醇 - 13 - 乙酸酯更有效,10 nM的苔藓抑素1可实现最大程度的下调。苔藓抑素1还增加了细胞对CP类似物顺二氯(乙二胺)铂(II)的敏感性。用1 nM苔藓抑素1进行24小时预处理可使细胞内顺式 - [3H]DEP增加60%。苔藓抑素1对CP敏感性的浓度和时间依赖性增强与顺式 - [3H]DEP水平的增加有关。因此,CP的细胞积累可能受PKC依赖性磷酸化事件的调节。

相似文献

1
Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.苔藓抑素1使人类宫颈癌细胞对顺二氯二氨铂(II)敏感化。
Cancer Res. 1992 Jun 1;52(11):3119-24.
2
Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.蛋白激酶C激活剂林比毒素A的新型类似物对顺二氯二氨铂(II)的细胞致敏作用。
Cancer Res. 1991 May 15;51(10):2511-4.
3
Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.顺铂敏感和耐药的人小细胞肺癌细胞中蛋白激酶C信号转导途径的特征分析
Cell Growth Differ. 1996 Nov;7(11):1507-12.
4
Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.苔藓抑素1增强顺铂耐药人宫颈癌细胞对顺铂的敏感性
Clin Cancer Res. 2005 Sep 15;11(18):6730-7. doi: 10.1158/1078-0432.CCR-05-0450.
5
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.苔藓抑素1和2对SH-SY5Y人神经母细胞瘤细胞形态和功能分化的影响。
Cancer Res. 1990 Jun 1;50(11):3422-8.
6
Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.苔藓抑素1影响P-糖蛋白磷酸化,但不影响多药耐药人乳腺癌细胞的功能。
Clin Cancer Res. 1995 Dec;1(12):1581-7.
7
Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.Jurkat T细胞对佛波酯和苔藓抑素的反应。具有不同功能反应的亚系的发育及蛋白激酶C活性的变化。
J Immunol. 1991 Nov 15;147(10):3474-81.
8
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.苔藓抑素1、苔藓抑素2和12-O-十四酰佛波醇-13-乙酸酯对A549人肺癌细胞蛋白激酶C活性影响的比较
Cancer Res. 1989 Jun 15;49(12):3242-5.
9
Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.苔藓抑素1和佛波酯对人乳腺癌细胞系的不同作用。
Cancer Res. 1992 Mar 1;52(5):1278-83.
10
Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.苔藓抑素1在抑制佛波酯诱导的分化的同时,保护小鼠角质形成细胞中的蛋白激酶C-δ不被下调。
Mol Pharmacol. 1994 Nov;46(5):840-50.

引用本文的文献

1
The Phylum Bryozoa: From Biology to Biomedical Potential.苔藓动物门:从生物学到生物医学潜力。
Mar Drugs. 2020 Apr 9;18(4):200. doi: 10.3390/md18040200.
2
Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.苔藓抑素-1通过蛋白激酶-Cδ的差异激活使BMG-1恶性胶质瘤细胞产生放射增敏作用,而在非恶性AA8成纤维细胞中不明显。
Mol Cell Biochem. 2015 Mar;401(1-2):49-59. doi: 10.1007/s11010-014-2291-0. Epub 2014 Dec 4.
3
Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
其脂溶性较低、合成更易的 bryostatin 7 的生物学特征与 bryostatin 1 极为相似。
ACS Chem Biol. 2013 Apr 19;8(4):767-77. doi: 10.1021/cb300671s. Epub 2013 Feb 1.
4
Role of the C8 gem-dimethyl group of bryostatin 1 on its unique pattern of biological activity.1 型苔藓抑素 C8 位偕二甲基在其独特生物活性模式中的作用。
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4084-8. doi: 10.1016/j.bmcl.2012.04.073. Epub 2012 Apr 24.
5
C1 Domain-targeted isophthalate derivatives induce cell elongation and cell cycle arrest in HeLa cells.C1 结构域靶向的邻苯二甲酸衍生物诱导 HeLa 细胞伸长和细胞周期停滞。
PLoS One. 2011;6(5):e20053. doi: 10.1371/journal.pone.0020053. Epub 2011 May 23.
6
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study.硼替佐米联合顺铂治疗复发性或持续性上皮性卵巢癌的Ⅱ期临床试验:加利福尼亚癌症联合会研究。
Invest New Drugs. 2012 Apr;30(2):723-8. doi: 10.1007/s10637-010-9557-5. Epub 2010 Oct 9.
7
Cellular responses to Cisplatin-induced DNA damage.细胞对顺铂诱导的DNA损伤的反应。
J Nucleic Acids. 2010 Aug 8;2010:201367. doi: 10.4061/2010/201367.
8
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.蛋白激酶C调节剂苔藓抑素1在难治性非血液系统肿瘤患者中先于顺铂的I期研究。
Cancer Chemother Pharmacol. 2009 Sep;64(4):803-10. doi: 10.1007/s00280-009-0931-y. Epub 2009 Feb 17.
9
A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.卡铂与大剂量长期他莫昔芬治疗复发性恶性胶质瘤的II期研究。
J Neurooncol. 2006 Jul;78(3):311-6. doi: 10.1007/s11060-005-9104-y. Epub 2006 May 19.
10
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.一项关于苔藓抑素-1(NSC #339555)用于持续性或复发性宫颈鳞状细胞癌的随机II期评估:一项妇科肿瘤学组研究。
Invest New Drugs. 2003 Nov;21(4):453-7. doi: 10.1023/a:1026255403046.